Oxford BioTherapeutics

Oxford BioTherapeutics is a biotech company in Oxford, United Kingdom.

Developing First-in-Class Cancer Therapies

Indexed holds 1 investor for this company. The full record is or through the API.

About

Oxford BioTherapeutics develops targeted oncology treatments, including antibody-drug conjugates, immuno-oncology therapies, T-cell engagers and radiopharmaceuticals. Its OGAP®-Verify proteomic platform identifies novel cancer targets to support next-generation antibody therapies. Through partnerships, the company advances first-in-class treatments intended to expand therapeutic options and improve outcomes for patients.

Summary

Investors include Silicon Valley Bank.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Company Event History

Data from Indexed.vcUpdated
Debt FinancingSilicon Valley Bank Capital Term LoanJul 2015
$10.0M

Investors

Similar Companies

Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Oxford BioTherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/oxford-biotherapeutics"><img src="https://indexed.vc/api/badge/company/oxford-biotherapeutics" alt="Oxford BioTherapeutics on Indexed.vc" width="260" height="76" /></a>